CHANP 201 PD
Alternative Names: CBT-NPC; CHANP-201 PD; Mesencephalic Neuronal Precursor Cells - CHA Bio & DiostechLatest Information Update: 31 Mar 2025
At a glance
- Originator CHA Bio & Diostech
- Class Cell therapies
- Mechanism of Action Cell replacements
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Phase I/II Parkinson's disease